Healthy subjects
Conditions
Interventions
Intake 5 capsules those contain test food three times a day (after each meal), for 12 weeks.
Intake 5 capsules those contain no test food three times a day (after each meal), for 12 weeks.
Sponsors
CPCC Company Limited
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1)Males and females aged 60 to 79 at resistration. 2)Subjects giving written informed consent.
Exclusion criteria
Exclusion criteria: 1) Subjects who constantly use medicines, supplements having a possibility of affecting test results. 2) Subjects who have previous and/or current medical history of serious disease such as cerebral infarction, cerebrovascular disease, psychosis, dementia and so on. 3) Subjects who excessive alcohol intake and excess smoker. 4) Subjects who have extremely irregular dining habits, and subjects who have midnight work or irregular shift work. 5) Subjects who have previous medical history of drug and/or food (especially gelatin) allergy. 6) Subjects who are participating the other clinical tests. Subjects who participated within 4-weeks prior to the current study and/or who plan to participate the other clinical tests. 7) Subjects who donated over 200mL blood and/or blood components within the last one month to the current study. 8) Males who donated over 400mL blood and/or blood components within the last three month to the current study. 9) Females who donated over 400mL blood and/or blood components within the last four month to the current study. 10) Males who will be collected over 1200mL blood and/or blood components, when the sampling amounts within the last twelve month are adding to the planned sampling amounts of this study. 11) Females who will be collected over 800mL blood and/or blood components when, the sampling amounts within the last twelve month are adding to the planned sampling amounts of this study. 12) Subjects who are positive for infectious. 13) Others who have been determined ineligible by principal investigator or sub-investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| MMSE-J score | — |
Secondary
| Measure | Time frame |
|---|---|
| MCI screening test, Brain blood flow measurement using NIRS, Self-rating Depression Scale developed by Zung, Social Readjustment Rating Scale by Holmes, Uchida-Kraepelin test, BAP test and quantification of cortisol in salivary | — |
Countries
Japan
Contacts
Public ContactMakoto Ichinohe
CPCC Company Limited Sales & Planning Department
Outcome results
None listed